You are here: Industry Insights > multiple myeloma

News List

Janssen seeks USFDA nod for Darzalex to treat ASCT multiple myeloma biospectrumasia
March 15, 2019
Janssen announced the submission of a supplemental Biologics License Application (sBLA) to FDA for Darzalex to treat ASCT multiple myeloma
FDA Approves DARZALEX Split-Dosing Regimen americanpharmaceuticalreview
February 13, 2019
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) has approved a split-dosing regimen for DARZALEX (daratumumab) .....
AbbVie and Teneobio to co-develop new drug for multiple myeloma pharmaceutical-technology
February 13, 2019
AbbVie has entered a strategic collaboration with biotechnology company Teneobio and its affiliate TeneoOne for the development and commercialisation of a multiple myeloma candidate TNB-383B.....
Takeda maintenance data set up Ninlaro for new myeloma nod fiercepharma
December 05, 2018
Takeda’s Ninlaro has watched from the sidelines as competing multiple myeloma drugs jumped into additional indications. But now it may finally be ready to do the same.
ASH: Johnson & Johnson's fast-growing Darzalex lines up for 2nd front-line myeloma OK fiercepharma
December 05, 2018
Johnson & Johnson’s Darzalex made multiple myeloma history this May when it became the first monoclonal antibody to score an FDA approval in newly diagnosed patients. And now, it’s looking to make it a repeat.
Former major leaguers take the field for Amgen’s new multiple myeloma campaign fiercepharma
July 26, 2018
Retired All-Star major leaguers are busy again this summer pitching for Amgen’s multiple myeloma push.
EU expands scope of Amgen’s Xgeva pharmatimes
July 18, 2018
European regulators have expanded the treatment scope of Amgen’s Xgeva to include the prevention of skeletal-related events in adults with multiple myeloma.
NICE turns down Darzalex combo for pre-treated multiple myeloma pharmatimes
July 13, 2018
Janssen says it is disappointed that NHS cost regulators are not backing NHS use of Darzalez (daratumumab) plus bortezomib and dexamethasone (DBd) for previously treated multiple myeloma in adults.
Darzalex combo wins nod for newly diagnosed multiple myeloma pharmatimes
July 09, 2018
Janssen/Genmab's Darzalex has become the first monoclonal antibody to be approved in the US to treat patients newly diagnosed with multiple myeloma.
AbbVie, IMF collaborate to manage multiple myeloma biospectrumasia
March 23, 2018
Study will provide insight into the relatively unknown role of genetic mutations in response to treatment and the corresponding outcomes in patients with MM

Previous page 1 2 3 4 5 6 7 8 9 Next page